Mental health in China and India: a growing storm. by Milner, James
Milner, J. (2016) [Accepted Manuscript] Mental health in China and
India: a growing storm. The Lancet Psychiatry. ISSN 2215-0366
DOI: 10.1016/S2215-0366(16)30173-0 (In Press)
Downloaded from: http://researchonline.lshtm.ac.uk/3029330/
DOI: 10.1016/S2215-0366(16)30173-0
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
  
Comment 
Mental, neurological, and substance use disorders in China 
and India 
 
 
Author: James Milner (james.milner@lshtm.ac.uk) 
 
Affiliation: London School of Hygiene & Tropical Medicine 
 
Address: Department of Social & Environmental Health Research, London School of Hygiene & 
Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK 
 
Corresponding author: Dr James Milner (james.milner@lshtm.ac.uk, +44 (0)20 7927 2510) 
  
Main text 
Mental, neurological, and substance use (MNS) disorders represent a major and increasing global 
health challenge. The issue has so far failed to receive the attention afforded to the protection of 
physical health and has, crucially, received lower levels of funding in all countries of the world.1 
Notable among these are the growing economies of China and India where rapid development over 
recent decades is likely to have contributed to increased prevalence of MNS disorders. The most 
recent 2013 Global Burden of Disease (GBD) study estimated that, added together, China and India 
represent an astonishing one-third of the global mental health burden.2,3 Responsible factors include 
the rising levels of inequality in the two countries and rapid changes in social structure and 
community cohesion.4 At the same time, as levels of urbanization have increased, large numbers of 
people have been exposed to environmental and psychological stressors including pollution, noise, 
poor housing and social isolation.5 To date, relatively little progress has been made in collecting data 
on the scale of the problem. 
In The Lancet Psychiatry, Amanda Baxter and colleagues report prevalence of MNS disorders for 
China and India as part of the “China-India Mental Health Alliance” landscaping paper series.6 The 
authors drew on findings from the GBD 2013 study to derive estimates of prevalence for 15 
disorders in 1990 and 2013. These disorders included schizophrenia, bipolar disorder, depressive 
disorders (including major depressive disorder (MDD) and dysthymia), anxiety disorders, attention-
deficit/hyperactivity disorder (ADHD), conduct disorder, autism spectrum disorder (ASD), alcohol 
dependence, drug use disorders, dementia and epilepsy.  
The results suggest that in 2013 the most common MNS disorders were similar in the two countries. 
For males, these were MDD, anxiety disorders and alcohol dependence and, for females, anxiety 
disorders, MDD and dysthymia. The authors estimate that at any one time during 2013, MDD and 
anxiety affected roughly 41 million and 40 million people, respectively, in China and 49 million and 
37 million people, respectively, in India. There were also some important differences between the 
two countries, with the far higher prevalence of schizophrenia in China being of particular note. 
Comparing the estimates against those for 1990, the authors identified two important 
developments. First, the number of people affected by MNS disorders grew more rapidly over the 
period in India (consistent with India’s greater rate of population growth) and, second, disorders 
with onset in younger age groups experienced much lower growth in China (including decreases in 
the number of cases of ADHD and conduct disorder). However, it is worth noting that these trends 
over time were not statistically significant. 
The work provides the best and most reliable estimates of the prevalence of MNS disorders in China 
and India to date. These estimates are vital to ensuring successful public health planning in the two 
countries. The results must however be viewed in the context of the limitations of the available 
information. Population representative prevalence data were found to be highly limited, particularly 
so in India (average coverage of just 1% by the authors’ estimation). Very few national-level studies 
were identified (one study in China, none in India) and data were unevenly distributed across 
disorders, age groups, regions and epidemiological parameters. Nonetheless, identifying these gaps 
in the available data is beneficial in itself. 
Despite the uncertainties, it is clear that the prevalence of MNS disorders in China and India is 
substantial and the number of people affected has grown considerably over recent decades. The 
problem may worsen further as both populations continue to age. The data presented in this paper 
can help to develop surveillance strategies for MNS disorders in the two countries. The challenge 
now is to harness recent improvements in awareness and developments in evidence, to which this 
study adds. The inclusion of mental health in the Sustainable Development Goals (SDGs), which will 
define the development agenda until 2030, is an encouraging move. Reflecting the growing 
importance of global mental health, SDG goal 3 (“Ensure healthy lives and promote well-being for all 
at all ages”) includes targets encouraging countries to “by 2030, reduce by one third premature 
mortality from noncommunicable diseases through prevention and treatment and promote mental 
health and well-being” and to “strengthen the prevention and treatment of substance abuse, 
including narcotic drug abuse and harmful use of alcohol”.7 It remains to be seen how seriously 
these commitments will be taken; little will be achieved without considerable long-term investment 
and political will. The SDGs can at least play an important role in focusing the efforts of the public 
health and development communities. The positive news for China and India is that MNS disorders 
are highly treatable and preventable using interventions that are practical and affordable.8 The 
protection of mental health must now be made a priority in both countries. Understanding the 
extent of the problem is an important step. 
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